Biogen Exec Denies That New Alzheimer’s Medicine Will Overwhelm Medicare — But Experts Disagree Chirfi Guindo, Head of Global Product Strategy and Commercialization, says he doesn’t think there will be millions of patients taking the company’s controversial new drug.